PharmaCross
ActiveFrom the official registers: KBO 18 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
PharmaCross has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.2m and a net result of €503,893. Equity is growing by about 3.1% per year across the filed financial years. Its solvency ranks better than 41% of 6,158 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Directors
Directors
1 director
Vander Cruyssen Danny
Current
Mandate history
1 person, 1 in office
- Board
| Name | Functions and periods |
|---|---|
| Vander Cruyssen Danny |
|
How the board is organised
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- The sole directordeed of 27-05-2025
- Board ruleHow the board is made up, meets and takes decisions.
- “Bestuursorgaan, algemene vergadering”deed of 08-06-2022 (in Dutch)
- Permanent representativeA company that is a director names a natural person to carry out the mandate on its behalf.
- “Bestuurder”deed of 08-06-2022 (in Dutch)
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Vormen vereist voor statutenwijziging, beslissing algemene vergadering”
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Bevoegdheden te omlijnen, om welke reden en op welk ogenblik ook”
deed of 08-06-2022 (in Dutch)
Owners and capital
Capital and shareholders
Shareholders according to the deeds
Stated in the act
act of 08-08-2025 ↗
- SKYPHARMA LIMITED all shares
Shares according to the articles of association
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- “100, Ieder aandeel geeft een gelijk recht in de winstverdeling en in het vereffeningsaldo”
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Werkelijke waarde op datum aangetekende brief verzoek,door expert door beide partijen aangesteld,geen akkoord over een deskundige ieder…”
- Share issue ruleHow and by whom new shares can be issued.
- “15, blote eigenaar vergoedt vruchtgebruiker voor waarde vruchtgebruik op voorkeurrecht”
deed of 08-06-2022 (in Dutch)